Feed SLP
SL

Simulations Plus, Inc.

SLP · NASDAQ

$18.42 -0.22% (-$0.04)
1M +0.60%
Market Cap $372.5M
P/E Ratio 45.96x
Div. Yield -
ROE 6.18%

Bulios Fair Price

$10.32

44.0% downside

Trenutna cena

$18.42

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica SLP trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
7/9
Valuation
76 /100
Cheap
P/E 45.96x
EV/EBITDA 25.81x
P/S 4.54x
Growth
43 /100
Stable
Rev. growth 13.67%
FCF growth 7.72%
Book val. growth 11.20%
Profitability
71 /100
Strong
Gross margin 63.38%
Net margin 9.88%
Op. margin 14.02%
Quality
31 /100
Poor
ROIC 5.32%
ROE 6.18%
ROA 5.30%
Debt
100 /100
Low
Debt/Equity 0.00x
Current ratio 5.54x
Net debt/EBITDA -2.66x
Stability
49 /100
Moderate
Beta 1.33x
Rev. volatility 3.54%
EPS volatility 431.94%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SLP
Online

O podjetju

Simulations Plus is an American company focused on the development and provision of software solutions in the pharmaceutical and biotechnology research field. The company's main headquarters is located in Lancaster, California. Simulations Plus specializes in developing models and simulations for pharmacokinetics, pharmacodynamics, and other aspects of drug research.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Technology

Industry

Software - Application

CEO

Shawn O'Connor

Employees

213

Headquarters

Research Triangle Park

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

47d
07 DEC.

Earnings

Upcoming earnings report

86d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.